Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Reschke

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 21, 2020
Rechallenge with checkpoint inhibitors in metastatic melanomaRobin Reschke, Mirjana Ziemer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 16, 2020
Robin Reschke, Mirjana Ziemer
Cancers|May 28, 2022
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to ImmunotherapyRobin Reschke, Daniel J Olson
Oncoimmunology|April 10, 2023
Tissue-resident memory T cells in immune-related adverse events: friend or foe?Robin Reschke, Thomas F Gajewski
Cancers|March 28, 2024
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 2458Robin Reschke, Daniel J Olson
Science Immunology|July 22, 2022
CXCL9 and CXCL10 bring the heat to tumorsRobin Reschke, Thomas F Gajewski
JAMA Dermatology|December 13, 2018
Recurrent Bullous Eruption in a Young WomanRobin Reschke, Konstantin Dumann, Mirjana Ziemer
Deutsches Arzteblatt International|September 27, 2019
Scleroderma en Coup de SabreRobin Reschke, Volker Schuster, Manfred Kunz
Journal of Clinical Medicine|April 12, 2022
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years)Robin Reschke, Konstantin Dumann, Mirjana Ziemer
Deutsches Arzteblatt International|November 2, 2022
Gummatous Cutaneous SyphilisRobin Reschke, Manfred Kunz, Mirjana Ziemer
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 21, 2020
Rechallenge with checkpoint inhibitors in metastatic melanomaRobin Reschke, Mirjana Ziemer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 16, 2020
Robin Reschke, Mirjana Ziemer
Cancers|May 28, 2022
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to ImmunotherapyRobin Reschke, Daniel J Olson
Oncoimmunology|April 10, 2023
Tissue-resident memory T cells in immune-related adverse events: friend or foe?Robin Reschke, Thomas F Gajewski
Cancers|March 28, 2024
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 2458Robin Reschke, Daniel J Olson
Science Immunology|July 22, 2022
CXCL9 and CXCL10 bring the heat to tumorsRobin Reschke, Thomas F Gajewski
JAMA Dermatology|December 13, 2018
Recurrent Bullous Eruption in a Young WomanRobin Reschke, Konstantin Dumann, Mirjana Ziemer
Deutsches Arzteblatt International|September 27, 2019
Scleroderma en Coup de SabreRobin Reschke, Volker Schuster, Manfred Kunz
Journal of Clinical Medicine|April 12, 2022
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years)Robin Reschke, Konstantin Dumann, Mirjana Ziemer
Deutsches Arzteblatt International|November 2, 2022
Gummatous Cutaneous SyphilisRobin Reschke, Manfred Kunz, Mirjana Ziemer
Pageof 5